Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute, and Steering Committee Member at Lung Cancer Policy Network, shared a post on X:
“Thrilled to have good friend and colleague Hidehito Horinouchi come visit us at CUHK Medicine to share his insights in latest treatment approaches in EGFRpositive, NSCLC.
Even Tony Mok is keen to snap photos of his talk!”
Other articles featuring Herbert Loong on OncoDaily.
